Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »

Butalin

Main

You must sign in to use this servcie


Feedback - Please use the form below to send your query or comment

You must sign in to use this servcie

Username:
Password:

Info

Indications:

Prevention and treatment of reversible bronchospasm associated with asthma and other obstructive pulmonary diseases. Unlabeled Uses Adjunctive treatment of hyperkalemia in patients undergoing dialysis

Contraindications:

Cardiac tachyarrhythmias

Adverse reactions:

Cardiovascular Palpitations; tachycardia; elevated BP; chest tightness; angina. CNS Tremor; dizziness; hyperactivity; nervousness; headache; insomnia; weakness; drowsiness; restlessness. EENT Dry mouth; throat irritation. GI Nausea; vomiting; heartburn; diarrhea. Genitourinary Urinary retention. Respiratory Cough; bronchospasm; wheezing; dyspnea. Miscellaneous Flushing; sweating; anorexia; unusual sensory changes.

Interactions:

Beta-blockers Severe bronchospasms may be produced in asthmatic patients taking albuterol. Digoxin Albuterol may decrease serum digoxin levels. Diuretics ECG changes and hypokalemia associated with these diuretics may worsen with albuterol coadministration.

Warnings:

Pregnancy Category C . Lactation Unknown. Children Albuterol aerosol and inhalation powder in children younger than 4 yr of age and albuterol solution for inhalation in children younger than 2?yr of age not established. Labor and Delivery May inhibit uterine contractions. CV effects Toxic symptoms may occur in patients with CV disorders. CNS effects CNS stimulation may occur; use cautiously in patients with history of seizures or hyperthyroidism. Diabetes Dosage adjustment of insulin or oral hypoglycemic agent may be required. Excessive use Paradoxical bronchospasm and cardiac arrest have been associated with excessive inhalant use. Hypokalemia Decreases in potassium levels have occurred. Tolerance If previously effective dose fails to provide relief, therapy may need to be reassessed.

Form:

TABLET

Dosage and Administration

You must sign in to use this servcie

Technical Description

You must sign in to use this servcie





Forgot your password


sign up
Consultants Corner

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Poll

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details